CSL - Current Assets


CSL reported $11.85B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Arca Biopharma USD 395.25M 51.39M Mar/2026
aTyr Pharma USD 67.58M 178.23M Mar/2026
Bio Path USD 677K 14K Mar/2026
Brainstorm Cell Therapeutics USD 184K 123K Mar/2026
Cara Therapeutics USD 31.54M 6.9M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Curis USD 6.92M 7.5M Dec/2025
Esperion Therapeutics USD 459.46M 3.11M Mar/2026
Immunic USD 188.76M 165.89M Mar/2026
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
TherapeuticsMD USD 11.82M 303K Jun/2024